LA Private

Uncategorized

Positive aspects of Newcrest deal

There are some significant developments taking place in relation to the potential merger between Newcrest (ASX:NCM) and Newmont, as well as the future of the Havieron gold copper prospect. However, it is important to present the information in a more positive and optimistic light.  Newcrest and Newmont are currently finalising the financial and operational details […]

Positive aspects of Newcrest deal Read More »

Shares still at risk of correction, Central banks signalling more work, High recession risk

Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses developments in investment markets over the past week, economic activity trackers, major global economic events and Australia economic events. Investment markets and key developments over the past week Global share markets fell over the last week with renewed concerns about central bank

Shares still at risk of correction, Central banks signalling more work, High recession risk Read More »

Fortescue metals enters $8m farm-in and joint venture agreement with Strategic Resources

Australian iron ore giant Fortescue Metals Group (ASX:FMG) has secured an $8m farm-in and joint venture deal with ASX minnow Strategic Resources (ASX:SER) over its copper-nickel-gold tenements located in Canobie. These tenements are strategically positioned adjacent to Fortescue’s own assets in the highly prospective Mt Isa province of Queensland. Under the agreement, Fortescue will invest

Fortescue metals enters $8m farm-in and joint venture agreement with Strategic Resources Read More »

Cochlear’s $170 million Oticon acquisition faces hurdles from UK regulator

In a blow to Cochlear Limited (ASX:COH), the Australian hearing implant manufacturer, its planned acquisition of a Danish hearing implants business worth $170 million has been hit by the Competition and Markets Authority (CMA) in the United Kingdom. The CMA announced that it had no competition concerns regarding Cochlear’s acquisition of Oticon Medical’s cochlear implant

Cochlear’s $170 million Oticon acquisition faces hurdles from UK regulator Read More »